| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |